The Journal of Organic Chemistry
NOTE
(silica gel) eluting with 35% ethyl acetate and 65% hexanes furnished the
pure product as a white crystalline solid (6.73 g, 0.023 mol, 99% yield): mp
58-60 °C; 1H NMR(400 MHz, CDCl3) δ1.61-1.66 (m, 2H), 1.80-1.87
(m, 4H), 2.27 (s, 6H), 3.94 (t, 4H, J = 6.7 Hz), 6.78 (d, 4H, J = 7.9 Hz), 7.06
(d, 4H, J = 8.5 Hz); 13C NMR (100 MHz, CDCl3) δ 21, 23, 29, 68, 115,
129.9, 130.1, 157; MS (ESI) m/z 307.1 (M þ Na)þ; HRMS (ESI) calcd for
C19H24O2 (M þ Na)þ 307.1675, found 307.1740.
(m, 4H), 8.49 (s, 4H); 13C NMR (100 MHz, DMSO) δ 21, 23, 25, 30, 45,
46, 69, 113, 120, 130, 132, 133, 156; MS (ESI) m/z 397.1 (M - H)þ,
199.2 (M2þ/2)þ, 543.1(M2þ PF6-)þ; HRMS (ESI) calcd for C25H37-
3
O2N2 (M - H)þ 397.2855, found 397.2864.
’ ASSOCIATED CONTENT
S
1,5-Bis(2-formyl-4-methylphenoxy)pentane (2a). Compound
1a (1.58 g, 0.0055 mol) and Duff reagent (1.82 g, 0.0129 mol) were
dissolved in 20 mL of TFA and the reaction mixture was allowed to reflux
under N2 for 24 h. The mixture was concentrated, water was added, and the
aqueous layer was extracted with 50 mL of CH2Cl2. The organic layer was
separated, and the aqueous layer was acidified with concentrated HCl and
extracted with CH2Cl2 (2 ꢀ 50 mL). The combined organic layer was
washed sequentially with 4 N HCl (2 ꢀ 50 mL), 50 mL of a saturated
Na2CO3 solution, and 50 mL of brine. Removal of the solvent under vacuum
furnished the crude product as a brown gluey mass. Column chromatogra-
phy (silica gel) eluting with hexanes furnished the pure product as a white
crystalline solid (0.75 g, 0.0022 mol, 40%): mp 76-77 °C; 1H NMR (400
MHz, CDCl3) δ1.66-1.72 (m, 2H), 1.88-1.95 (m, 4H), 2.29 (s, 6H), 4.07
(t, 4H, J = 6.2 Hz), 6.96 (d, 2H, J = 8.7 Hz), 7.32 (d, 2H, J = 8.6 Hz), 7.61 (s,
2H), 10.46 (s, 2H); 13C NMR (100 MHz, CDCl3) δ20, 23, 29, 68, 113, 125,
130, 137, 160, 190; MS (ESI) m/z 409.0 (M þ Na)þ; HRMS (ESI) calcd
for C21H24O4 (M þ Na)þ 363.1572, found 363.1584.
Supporting Information. Full characterizations for 1b,
b
1c, 2b, 2c, 3b, 3c, 3e, 3f, 4b, 4c, 4e, and 4f, HRMS, 1H NMR, and
13C NMR spectra of 1a-c, 2a-c, 3a, 3b, 3c, 3e, 3f, and 4a-g,
1H NMR spectra of TBAPG, Job plots of receptors 4a, 4b, 4c,
-
-
and 4f with TBA H2PO4 and of 4e with TBA H2PO4 or
1
TBAPG, stacked plots of H NMR titrations of 4e þ TBA
H2PO4 or TBAPG, and ITC binding isotherms of 4e þ TBA
H2PO4 or TBAPG, and X-ray crystal structures for anion-
-
-
receptor complexes of 4f þ 2H2PO4 and for 4c þ 2PF6
,
and estimated complex structure 4b þ H2PO4-. This material is
’ AUTHOR INFORMATION
Corresponding Author
*E-mail: dennis.burns@wichita.edu.
10,21-Dimethyldibenzo-[h,r]-1,7-dioxa-13,18-diaza-2,3,
4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclo-
nonadecene (3a). Compound 2a (0.06 g, 0.176 mmol) was
suspended in 22 mL of dry ethanol and purged with dry N2 for 30
min, then the reaction was brought to reflux. Butane-1,4-diamine
(0.0224 mL, 0.222 mol) in 9 mL of dry ethanol was added dropwise to
the reaction mixture. The reaction was allowed to reflux for 20 h, and
the solvent was then removed under reduced pressure yielding the bis-
imine as a yellow solid, which was subjected to reduction without
further purification. The crude bis-imine was redissolved in 2 mL of
anhydrous methanol under N2. Pd-C (10%, 0.1 g) was added and the
reaction mixture was allowed to stir. Triethylsilane (1.0 mL, 0.006
mol) was added dropwise into the methanolic bis-imine solution with
an addition funnel, the top of which was attached to a rubber balloon.
After the addition was complete, the mixture was stirred for an
additional 6 h at room temperature. The reaction mixture was filtered
through Celite, and removal of the solvent under vacuum gave the
crude product as a yellow oil. Column chromatography (silica gel)
eluting with 10% CHCl3, 4% isopropylamine, and 86% diethyl ether
furnished compound 3a as an off-white solid (0.060 g, 0.151 mmol,
86% after both steps): mp 95-96 °C; 1H NMR (400 MHz, DMSO) δ
1.39-1.42 (m, 4H), 1.62-1.67 (m, 2H), 1.77-1.84 (m, 4H, J = 6.87
Hz), 2.21 (s, 6H), 2.47 (t, 4H, J = 5.6 Hz), 3.61 (s, 4H), 3.96 (t, 4H, J =
5.9 Hz), 6.85 (d, 2H, J = 8.2 Hz), 6.99 (d, 2H, J = 8.8 Hz), 7.04 (s, 2H);
13C NMR (100 MHz, DMSO) δ 21, 25, 27, 30, 48.3, 48.5, 69, 113,
128.7, 128.9, 129.4, 131, 156; MS (ESI) m/z 397.1 (M þ H)þ; HRMS
(ESI) calcd for C25H36O2N2 (M þ H)þ 397.2855, found 397.2852.
10,21-Dimethyldibenzo-[h,r]-1,7-dioxa-13,18-diaza-2,3,
4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclo-
nonadecenediium bis(hexafluorophosphate (4a). Bis-amine
3a (15 mg, 0.038 mmol) was dissolved in 3 mL of methanol, 6 N HCl
(2 mL) was added, and the reaction mixture was allowed to stir for 3 h at
room temperature. The solvent was removed under vacuumand the crude
reaction mixture was redissolved in 3 mL of H2O. Ammonium hexa-
fluorophosphate (>30 equiv) dissolved in CH2Cl2 was added and the
reaction mixture was stirred overnight during which time 4a precipitated
from the solvent mixture as an off-white solid (24 mg, 0.034 mmol, 92%):
mp >165 °C dec; 1H NMR (400 MHz, DMSO) δ 1.71 (s, broad, 6H),
1.82-1.87 (m, 4H, J = 5.9 Hz), 2.26 (s, 6H), 2.92 (s, broad, 4H), 4.04
(t, 4H, J = 5.4 Hz), 4.08 (s, 4H), 7.01 (d, 2H, J = 8.7 Hz), 7.21-7.23
’ ACKNOWLEDGMENT
The authors thank Professor David M. Eichhorn and John C.
Bullinger for the acquisition of the X-ray structures. The authors
thank Professor Franz P. Schmidtchen for helpful discussions
regarding the use of ITC.
’ REFERENCES
(1) Bhattacharjya, S.; Ramamoorthy, A. FEBS J. 2009, 276, 6465–6473.
(2) Savage, P. Ann. Med. 2001, 33, 167–171.
(3) Hancock, R. E. W.; Patrzykat, A. Curr. Drug Targets: Infect.
Disord. 2002, 2, 79–83.
(4) Kustanovich, I.; Shalev, D.; Mikhlin, M.; Gaidukov, L.; Mor, A.
J. Biol. Chem. 2002, 277, 16941–16951.
(5) Tew, G. N.; Scott, R. W.; Klein, M. L.; Degrado, W. F. Acc. Chem.
Res. 2010, 43, 30–39.
(6) Ibrahim, H. R.; Aoki, T.; Pellegrini, A. Curr. Pharm. Des. 2002, 8,
671–693.
(7) Auvynet, C.; Rosenstein, Y. FEBS J. 2009, 276, 6497–6508.
(8) Zasloff, M. Nature 2002, 415, 389–395.
(9) Devine, D.; Hancock, R. E. W. Curr. Pharm. Des. 2002, 8, 703–714.
(10) Scott, M.;Hancock, R. E. W.Crit. Rev. Immunol. 2000, 20, 407–431.
(11) Gallo, R.; Murakami, M.; Ohtake, T.; Zaiou, M. J. Allergy Clin.
Immunol. 2002, 110, 823–831.
(12) Bevins, C. Contrib. Microbiol. 2003, 10, 106–148.
(13) Removing polar solvent from charged systems requires suffi-
cient amounts of enthalpic energy such that the entropies of complexa-
tion and solvent reorganization dominate the binding thermodynamics;
see: Schmidtchen, F. P. Coord. Chem. Rev. 2006, 250, 2918–2928.
(14) The synthesis of the tetrabutylammonium phosphatidylglycer-
ol salt (TBAPG) will be reported elsewhere. The compound gave
satisfactory spectroscopic and HRMS analyses.
(15) Burns, D. H.; Calderon-Kawasaki, K.; Kularatne, S. J. Org.
Chem. 2005, 70, 2803–2807.
(16) Dilution studies with the TBAPG salt and the receptors were
conducted in DMSO-d6 or 95% DMF-d7/5% CDCl3 to determine the
appropriate concentrations for receptor and anion salts in the 1H NMR
stoichiometric studies.
(17) Sessler, J. L.; Gross, D. E.; Cho, W.-S.; Lynch, V. M.;
Schmidtchen, F. P.; Bates, G. W.; Light, M. E.; Gale, P. A. J. Am. Chem.
Soc. 2006, 128, 12281–12288.
1933
dx.doi.org/10.1021/jo102383j |J. Org. Chem. 2011, 76, 1930–1933